Jackson Square Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
1,195
-83
-6% -$28.4K 0.06% 107
2026
Q1
$450K Buy
+1,278
New +$456K 0.09% 101
2020
Q4
Sell
-261
Closed -$66K 156
2020
Q3
$66K Hold
261
0.03% 168
2020
Q2
$62K Sell
261
-31
-11% -$7.07K 0.03% 153
2020
Q1
$59K Buy
292
+14
+5% +$3.06K 0.05% 113
2019
Q4
$67K Buy
+278
New +$61.3K 0.04% 140

Other funds holding AMGN

Jackson Square Capital's AMGN Position: Q2 2026 in Review

Jackson Square Capital reduced its Amgen (AMGN) stake by 6.5% in Q2 2026, selling an estimated $28.4K and leaving 1,195 shares worth $433K. The position accounts for 0.06% of the portfolio, ranked #107.

Jackson Square Capital first reported a position in AMGN in Q4 2019 and has held it in 6 quarters since. The position peaked at $450K in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Jackson Square Capital held 1,195 shares of Amgen worth $433K as of Q2 2026.
  • Jackson Square Capital sold 83 Amgen shares in Q2 2026, an estimated $28.4K.
  • Amgen made up 0.06% of Jackson Square Capital's portfolio in Q2 2026, its #107 holding.
  • Jackson Square Capital first reported a position in Amgen in Q4 2019 and has held it in 6 quarters since.
  • Jackson Square Capital's Amgen position peaked at $450K in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.